Welcome to our dedicated page for Centene Del news (Ticker: CNC), a resource for investors and traders seeking the latest updates and insights on Centene Del stock.
Centene Corporation (NYSE: CNC), a leading provider of government-sponsored healthcare programs, offers investors and stakeholders timely access to its latest developments through this centralized news hub. Track official press releases, regulatory filings, and strategic initiatives from the Fortune 500 company driving innovation in Medicaid managed care and Medicare Advantage plans.
This resource delivers essential updates including quarterly earnings reports, contract awards with state/federal agencies, partnerships advancing telehealth services, and expansions of behavioral health programs. Users will find verified information on Centene’s specialty services like pharmacy benefits management and corrections healthcare solutions.
Bookmark this page for direct access to CNC’s:
• Annual and quarterly financial performance
• Government program enrollment updates
• Strategic acquisitions in healthcare services
• Regulatory compliance milestones
Monitor Centene’s progress in addressing healthcare disparities through its integrated care models and value-based initiatives. Return regularly for unfiltered updates directly from corporate communications and SEC filings.
Centene Corporation (NYSE: CNC) has signed a definitive agreement to sell its Spanish and Central European businesses to Vivalto Santé, as part of its strategic portfolio review. This transaction includes Ribera Salud, a healthcare provider in Spain, and Pro Diagnostics Group, which operates clinics in Slovakia and the Czech Republic. Centene plans to use most of the net proceeds for stock repurchases and the remainder to reduce debt. The transaction is expected to be neutral to adjusted diluted earnings per share over the 12 months following its closing, anticipated by year-end 2022.
Health Net has awarded a $120,000 grant to the Vouchers 4 Veggies program to help combat food insecurity in San Joaquin, Sutter, and Yuba counties. This initiative aims to provide low-income families with access to fresh produce. Since November 2021, over 250 households have benefited from food vouchers. This grant is part of Health Net's broader effort to enhance community health and tackle food insecurity affecting millions in California.
Centene Corporation (NYSE: CNC) has completed the divestiture of its pharmacy business, PANTHERx, to Vistria Group, General Atlantic, and Nautic Partners as part of its ongoing value creation strategy.
Proceeds from the sale will primarily be used for stock repurchases and debt reduction. The divestiture allows Centene to concentrate on its core business, enhancing its focus on delivering integrated, high-quality healthcare services.
Centene Corporation announced the intent to award a contract to its subsidiary, Delaware First Health, to manage Medicaid services in Delaware, marking its 30th state in the Medicaid managed care sector. The contract, effective January 1, 2023, includes providing integrated services for physical and behavioral health. With nearly 40 years of Medicaid experience, Centene aims to enhance health outcomes for Delaware residents while focusing on value-based care.
Centene Corporation (NYSE: CNC) announced the release of its 2022 second quarter financial results on July 26, 2022, at 6 a.m. Eastern Time. A conference call will follow at 8:30 a.m. Eastern Time to discuss the results. Interested parties can participate by calling 1-877-883-0383 in the U.S. or via international dialing. The call will also be available as a live audio webcast on Centene's website, with a replay accessible for 12 months. Centene, a Fortune 500 company, focuses on delivering integrated healthcare services, particularly to under-insured individuals.
Centene Corporation (NYSE: CNC) has updated its 2022 guidance, increasing Premium and Service Revenues by $2.0 billion to a range of $134.3 billion to $136.3 billion and Adjusted Diluted EPS guidance to $5.55 to $5.70. The company plans to reduce its real estate footprint, anticipating one-time costs of $1.5 to $1.65 billion but expects to cut annualized leased real estate expenses by $180 million to $200 million. Additionally, the Board has authorized a $3 billion increase to its stock repurchase program and a $1 billion debt repurchase program.
Health Net, a leading Medi-Cal partner in California, has announced a collaboration with MedArrive to provide in-home COVID-19 vaccinations for vulnerable members and their families. This initiative targets areas like Los Angeles, Sacramento, and Fresno, facilitating access for those facing social and economic barriers. Eligible members can schedule home visits with licensed healthcare professionals. The program is part of Health Net's broader efforts to enhance health equity and increase vaccination rates among underserved populations in California.
Centene Corporation (NYSE: CNC) will hold a virtual Investor Meeting on June 17, 2022. The meeting will feature insights from senior management and will be live-streamed on the Centene website under the Investors section. Centene, a Fortune 25 healthcare leader, focuses on providing high-quality and cost-effective services to under-insured and uninsured individuals. The company serves nearly 1 in 15 people in the U.S. and operates in international markets, ensuring long-term growth and value creation for its members and community.